EasyMed Services Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) ("ESI") would
like to add further pertinent background details of its intended
partner Biosign Technologies Inc. (TSX VENTURE:BIO) ("Biosign") for
our investors. Due to some diffusion issues, a background to Biosign
in our announcement dated April 2nd was not relayed.
We were pleased to announce on April 2nd that ESI have entered into a
letter of intent dated April 1, 2012 (the "Letter of Intent") with
Biosign Technologies Inc. (TSX VENTURE:BIO) ("Biosign") to complete a
business combination (the "Transaction"). BIO, a public company with
headquarters in Toronto, Canada, provides biomedical systems. Key
applications include intelligent systems for non-invasive monitoring
of common health risks associated with blood pressure, glucose, and
medication. The core technology combines measurement, analysis, and
rapid knowledge formation to support health monitoring across global
markets. Upon completion of the Transaction, it is intended that the
combined entity will continue to carry on the business of ESI and will
be listed on the TSX-V.
For full information on the proposed transaction between ESI and
Biosign please refer to the press release dated on April 2nd 2012.
We outline for our investors a description of Biosign to allow them to
fully understand Biosign's extremely compatible resources with ESI
Information Concerning Biosign. Biosign Technologies Inc. is a public
company traded on the TSX - Venture Exchange ("TSX-V") under the
symbol BIO and was formed via an amalgamation under the Business
Corporations Act (Ontario) on July 14, 2006. The predecessor operating
company was Biosign Technologies Inc. which was incorporated under the
Business Corporations Act (Ontario) on March 11, 2004.
Biosign is an ISO 13485 Certified Medical Device company that has
invested in excess of $15million to develop technologies, products and
initiatives to address critical problems in global health care.
Biosign is committed to becoming the "world's health monitor" with a
robust, integrated and portable system that provides valuable
information to stakeholders. Biosign's breakthrough technology and
continued innovation serve the Company's mission to make health care
safe, simple, and sensible.
Biosign provides an end-to-end solution for non-invasive monitoring,
analysis and reporting of health data critical to the management of
cardiovascular conditions through their proprietary platform "UFIT".
The UFIT@ cuff painlessly captures the pulse waveform from the
patient's pulse and transmits it to the cloud through a computer.
Biosign proprietary algorithms analyze the data in seconds to report
blood pressure and other cardiovascular measurements. Biosign's
analysis and reporting tools give patients and their healthcare team
secure access to real-time and longitudinal health information for
treatment planning, evaluation, and management.
In October 2010 Biosign acquired Healthanywhere ("HA") for
consideration of approximately $3,400,000. The HA intellectual
property includes a 510k clearance from the U.S. Food and Drug
Administration for the HA solution as a Class II medical device. HA
provides software solutions addressing the continuum of care from
wellness promotion and self-managed care to chronic disease
ESI Chief Executive Officer Andrew Ritchie commented: "We want to
inform our shareholders and the broader investment community of the
great rationale for the proposed merger between these two companies.
After having executed the Joint-Venture agreement with Biosign earlier
this year it became evident that a merger was the right way forward to
maximize both companies' unique technical and human resources in the
domain of telemedicine."
About EasyMed Services Inc.
EasyMed Services, Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) is a global
medical information technology company delivering an end to end
patient care solution through mobile phone/PDA and server technologies
offering specialized services and applications for healthcare,
insurance and pharmaceutical industries. We are committed to
world-class customer service and the protection of our clients'
For more information, visit www.easymedservices.com.
This news release contains forward-looking statements, which relate to
future events or future performance and reflect management's current
expectations and assumptions. These forward-looking statements reflect
management's current beliefs and are based on assumptions made by and
information currently available to the Company. Investors are
cautioned that these forward looking statements are neither promises
nor guarantees, and are subject to risks and uncertainties that may
cause future results to differ materially from those expected. These
forward-looking statements are made as of the date hereof and, except
as required under applicable securities legislation, the Company does
not assume any obligation to update or revise them to reflect new
events or circumstances.
The CNSX has not reviewed and does not accept responsibility for the
adequacy or accuracy of this release.